Ubrogepant

Ubrogepant, also known as MK-1602, is a potent and selective oral calcitonin gene-related peptide (CGRP) receptor antagonist.

Online Inquiry

Specification Technical Data Related Products Customer reviews and Q&A Useful Tools Publications

CAT#	10-101-185
CAS	1374248-77-7
Synonyms/Alias	MK-1602; MK 1602; MK1602
M.F/Formula	C29H26F3N5O3
M.W/Mr.	549.5542
Labeling Target	Histone deacetylase
Application	Ubrogepant is investigated for acute treatment of migraines.
Appearance	Solid powder
Purity	>98% (or refer to the Certificate of Analysis)
Activity	Antagonist
Biological Activity	Ubrogepant (MK-1602) is a novel oral calcitonin gene-related peptide receptor (CGRP) antagonist in development for acute treatment of migraine.
Target	CGRP Receptor

CAT#	Product Name	Inquiry
10-101-272	Gly-Glu-Gly	Inquiry
10-101-109	Antazoline Phosphate	Inquiry
Z10-101-156	Rapamycin	Inquiry
10-101-60	Abarelix	Inquiry
10-101-335	Mecasermin	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Source#	Synthetic
Storage	-20°C
Solubility	Soluble in DMSO, not in water
Shipping Condition	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Short-term Storage Conditions	Dry, dark and at 0 - 4 °C
Long-term Storage Conditions	-20 °C
InChI	InChI=1S/C29H26F3N5O3/c1-16-20(17-6-3-2-4-7-17)11-22(26(39)37(16)15-29(30,31)32)35-25(38)19-10-18-12-28(13-23(18)34-14-19)21-8-5-9-33-24(21)36-27(28)40/h2-10,14,16,20,22H,11-13,15H2,1H3,(H,35,38)(H,33,36,40)/t16-,20-,22+,28+/m1/s1
InChI Key	DDOOFTLHJSMHLN-ZQHRPCGSSA-N
Isomeric SMILES	C[C@@H]1[C@@H](C[C@@H](C(=O)N1CC(F)(F)F)NC(=O)C2=CC3=C(C[C@@]4(C3)C5=C(NC4=O)N=CC=C5)N=C2)C6=CC=CC=C6
BoilingPoint	942.8±65.0 °C at 760 mmHg
ShelfLife	>2 years if stored properly
Melting Point	N/A